Enamine contributes to the discovery of promising broad-spectrum coronavirus antiviral

KYIV, Ukraine – Enamine, a leading chemistry and R&D services company, today announced its key role as a synthetic chemistry contributor to a pioneering open-science initiative. This collaborative effort led to the development of a promising broad-spectrum coronavirus antiviral pre-clinical candidate.

Enamine’s advanced chemistry platform delivered over 2,000 new compounds during the early stages of the program, driving the discovery of the pre-clinical candidate known as ASAP-0017445.

http://www.businesswire.com/news/home/20251020706999/en/Enamine-contributes-to-the-discovery-of-promising-broad-spectrum-coronavirus-antiviral/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==